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Abstract
Background: Little research exists on the effectiveness of motivational interviewing (MI) on return to work (RTW) in
workers on long term sick leave. The objectives of this study protocol is to describe a randomized controlled trial
(RCT) with the objectives to compare the effectiveness and cost-effectiveness of usual case management alone
with usual case management plus MI or usual case management plus stratified vocational advice intervention
(SVAI), on RTW among people on sick leave due to musculoskeletal (MSK) disorders.
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Methods: A multi-arm RCT with economic evaluation will be conducted in Norway with recruitment of 450
participants aged 18–67 years on 50–100% sick leave for > 7 weeks due to MSK disorders. Participants will be
randomized to either usual case management by the Norwegian Labour and Welfare Administration (NAV) alone,
usual case management by NAV plus MI, or usual case management by NAV plus SVAI. Trained caseworkers in NAV
will give two MI sessions, and physiotherapists will give 1–4 SVAI sessions depending upon risk of long-term sick
leave. The primary outcome is the number of sick leave days from randomization to 6 months follow-up. Secondary
outcomes are number of sick leave days at 12 months follow-up, time until sustainable RTW (≥4 weeks of at least
50% of their usual working hours) at 12 months, proportions of participants receiving sick leave benefits during 12
months of follow-up, and MSK symptoms influencing health at 12 months. Cost-utility evaluated by the EuroQoL
5D-5L and cost-benefit analyses will be performed. Fidelity of the interventions will be assessed through audio-
recordings of approximately 10% of the intervention sessions.
Discussion: The results from this RCT will inform stakeholders involved in supporting RTW due to MSK disorders
such as staff within NAV and primary health care.
Trial registration: ClinicalTrials.gov ID: NCT03871712 registered March 12th 2020.
Keywords: MSK disorders, Vocational interventions, Motivational interviewing, Sick leave, Return to work, Health
economics, Randomized controlled trial
Background
In Norway, musculoskeletal (MSK) disorders present the
greatest burden to future health and welfare services [1, 2].
The high economic costs related to sick leave include prod-
uctivity loss and use of health care services. Importantly,
through the Norwegian Labour and Welfare Administra-
tion (NAV), the welfare system in Norway covers 100% of
the worker’s salary up to 52weeks of sick leave after the
first 16 days, which are paid by the employer.
To address the substantial costs related to sick leave,
effective interventions targeting obstacles to return to
work (RTW) are needed. In a best evidence synthesis of
94 systematic reviews with half of the studies exploring
MSK disorders [3], risk factors associated with poorer
RTW outcomes were older age, being female, higher
pain or disability, depression, higher physical work de-
mands, previous sick leave, unemployment, and activity
limitations. Better RTW outcomes were found in people
with higher education and socioeconomic status, higher
self-efficacy beliefs, optimistic expectations for recovery,
lower severity of the injury/illness, better RTW coordin-
ation and in those receiving multidisciplinary interven-
tions involving the workplace and key stakeholders.
There is strong evidence that interventions with a
health focus, service coordination involving the work-
place, and work modifications reduce the proportion of
people on sick leave [4]. Motivational interviewing (MI)
[5] is an intervention that targets behavior change that
has been suggested to be useful in an RTW context [6].
A systematic review including five randomized con-
trolled trials (RCTs) reported weak evidence for the
effectiveness of MI to facilitate RTW, particularly for
people with less serious conditions and short work ab-
sences [7]. A recent systematic mapping review by our
research group [8] with the objective of mapping all
types of empirical research on MI as a method to help
people with MSK disorders return to work revealed only
three papers from two RCTs: A Norwegian RCT with
high risk of bias showed now effect of a brief interven-
tion including MI on RTW for 89 disability pensioners
with back pain [9], and a Canadian cluster RCT with
low risk of bias including 728 claimants with chronic
musculoskeletal disorders, showed that providing MI in
addition to usual rehabilitation increased RTW both at
discharge and at 1-year follow-up [10, 11].
Providing vocational interventions to all people having
any period of sick leave, that comprises individualized
cognitive, affective and behavioral approaches, would re-
quire enormous resources. Using a stratified approach in
which only individuals at high risk for long-term sick
leave are targeted with the intervention, could be more
efficient. Stratified care is one approach with which to
improve outcomes among people with MSK disorders.
By way of example, the STarT Back trial was the first
RCT to show that stratified care based on matching
treatment to low back pain patients’ risk of persistent
disabling pain (low, medium or high risk) resulted in
better patient outcomes including fewer days lost from
work, at less cost for the UK healthcare system and UK
society [12, 13]. Furthermore, a recent RCT [14] com-
pared the difference in the number of sickness absence
days between a targeted intervention that emphasized
communication (MI and problem-solving skills for the
patient and their work supervisor) versus treatment as
usual in people with back pain at high risk of persistent
pain. The targeted intervention resulted in fewer days off
work, fewer health care visits and better perceived
health. Despite promising results for low back pain, to
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date there are few studies on stratified care for the
broader group of people with MSK disorders. Several
tools have been developed with which to assess MSK
pain patients’ risk of persistent disabling pain, for in-
stance the Keele STarT MSK tool [15], and long-term
work loss [16]. A stepped care approach to facilitate
RTW was investigated in the Study of Work and Pain
(SWAP) cluster RCT in the UK [17]. General practices
were randomized to either offer usual care or the SWAP
intervention in addition to usual care. Patients consult-
ing general practices in the intervention arm with MSK
pain who were absent from work or struggling at work
were offered access to a vocational advice service,
whereby vocational advisors provided a case-managed
stepwise intervention, starting with brief telephone as-
sessment and advice, addressing obstacles to RTW [18].
The SWAP trial showed that participants in the voca-
tional advice arm had fewer days off work compared
with those having usual care alone.
There is lack of research of the effectiveness of MI and
vocational advice interventions in people on long term
sick leave due to MSK disorders. The objectives of this
RCT are thus to compare the effectiveness and cost-
effectiveness of usual case management by NAV alone
with usual case management by NAV plus MI or usual
case management by NAAV plus stratified vocational
advice intervention (SVAI), on RTW among people on
sick leave due to MSK disorders. The objectives and hy-
potheses are presented in detail the statistical analysis
plan in Appendix 1. This multi-arm RCT is not designed
to compare the two interventions head-to-head, as this
would have required an unrealistically large sample size.
In addition to analyses of effectiveness of the two inter-
ventions, we will conduct health economic analyses, me-
diation analyses, process evaluation, and exploratory
analyses of potential predictors for sick leave due to
MSK disorders.
Methods
Participants, interventions and outcomes
Study setting
This multi-arm RCT (Clinicaltrials identifier: NCT03871712)
is work package three (WP3) of the MI-NAV study (https://
www.muskhealth.com/minav) consisting of three WPs.
WP1 includes a systematic mapping review [8] and a
survey and focus group interview of NAV caseworkers
investigating usual NAV case management for individ-
uals on sick leave due to MSK disorders, and experi-
ences of the RTW process. In WP2, we will explore the
most accurate screening tool to identify people at a high
risk of prolonged sickness absence due to MSK disorder,
and investigate MSK health, health-related quality-of-life,
health care consumption, and costs across different risk
profiles in individuals on sick leave due to MSK disorders
[19]. The first phase of WP3 will be an internal pilot trial
including recruitment of the first 100 study participants.
We will assess whether the recruitment protocol, and the
randomization procedure, and that the interventions and
follow-ups will run as planned. If we do not need to do
changes in these parts after the pilot study, data from the
first 100 recruited will be included in the main trial. If
major changes to any of the recruitment, randomization
or intervention procedures will be needed, we will do the
protocol changes before starting the RCT or stop the trial
if it turns out to not be feasible.
The RCT is a collaboration project between the MUSK
Health research group at Oslo Metropolitan University
and NAV and will be conducted in the South-Eastern re-
gion of Norway. The recruitment of participants will be
conducted at the NAV Directorate in Oslo, Norway. The
RCT will be reported according to the CONSORT exten-
sion statement for multi-arm trials [20] and this protocol
is reported according to the Standard Protocol Items: Rec-
ommendations for Interventional Trials (SPIRIT) [21].
Eligibility criteria
People on sick leave because of any MSK disorder will
be eligible for inclusion if they are 18–67 years old and
have been on sick leave for > 7 weeks. Individuals with
full or part-time positions will be eligible if they are on
sick leave for at least 50% of their normal working hours,
and if they have a job to return to. The exclusion criteria
are serious somatic or mental health disorders (e.g. can-
cer, psychiatric disorders), pregnancy; self-employed
workers or freelancers, and insufficient Norwegian or
English communication skills to complete participant
questionnaires.
Interventions
All three arms of this RCT will be offered usual case
management from NAV caseworkers. The usual case
management should ideally follow this timeline: within
the first 4 weeks of sick leave, an RTW plan is made by
the employer and worker; within 7 weeks, a dialogue
meeting between the employee, employer and other rele-
vant stakeholders such as general practitioner (GP), is
arranged by the employer. Within week 26 of the sick
leave period, NAV arranges a second dialogue meeting
between the employee, the employer and in some cases
the GP who issued the sick leave.
The participants in the MI arm will, in addition, be of-
fered two MI conversations provided by trained NAV
caseworkers; the first as soon as possible after random
allocation, and the second two weeks later. NAV case-
workers will be educated in MI through a total of 7 in-
tensive course days given by a trained psychologist and a
psychiatrist (3 × 2 days + 1 day). In order to avoid con-
textual contamination, we have strived for collaboration
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with NAV offices where caseworkers have not used MI
in usual case management. The MI education includes
the MI principles: a) motivation to change is elicited
from the client, and is not imposed upon them by
others, b) it is the client’s task to articulate and resolve
ambivalence for change, c) direct persuasion is not an ef-
fective method for resolving ambivalence, d) adopt a
quiet counselling style to elicit information from the cli-
ent, e) the counsellor is directive in helping the client to
examine and resolve ambivalence, and f) readiness to
change is not a trait of the client, but a fluctuating result
of interpersonal interaction. The NAV case workers will
receive a written manual with guidelines on how to con-
duct the MI in the RCT and will be mentored by a
psychologist throughout the intervention period.
The participants in the SVAI arm will, in addition to
usual case management, be offered 1–2 telephone calls
for the low/medium risk group or 3–4 telephone calls
and/or face-to-face meetings for the high-risk group.
The 10-item Keele STarT MSK tool and the 10-item
version of the Örebro MSK Pain Screening Question-
naire Short Form (ÖMPSQ-SF) will be used in combin-
ation to stratify the participant into one of two risk
groups before group allocation: low/medium risk of
long-term sick leave or high risk of long-term sick leave
[22]. The Keele STarT MSK tool [15] consists of 10
items (scores range from 0 to 12) that together predict
persistent disabling pain and stratifies patients into low,
medium or high risk subgroups. The Norwegian version
of this tool has been translated and cross-culturally
adapted to Norwegian among people on sick leave due
to MSK disorders included in a sub-study of the MI-
NAV project (manuscript to be published). The short
10-item version of the ÖMPSQ-SF [16] is a screening
tool developed to assist in the early identification of
those at high risk of work disability. It contains import-
ant risk factors for long-term sickness absence due to
MSK disorders, including items assessing pain catastro-
phizing and fear-avoidance beliefs, depression, anxiety,
and RTW expectancy. To ensure both high sensitivity
and specificity, we will use both these instruments to
screen the participants to low/medium or high risk of
long-term sick leave groups. In the current RCT, partici-
pants will be allocated to the high-risk subgroup if they
have ≥9 points (out of 12) on the Keele STarT MSK tool
and ≥ 60 points (out of 100) on the ÖMPSQ-SF at base-
line. These cut offs are based on preliminary data from
WP2 of this project [19].
Eight physiotherapists will be trained over a five-day
course to provide SVAI. They will give the intervention
to the participants in the SVAI arm as follows; the first
contact should ideally be within a week after allocation.
This intervention will stop by week 26 of the sick leave
period or if the participant has returned to work for
more than 4 weeks in the same working hours as they
had before going on sick leave. The physiotherapists will
receive monthly mentoring during the intervention
period by the course instructor (GS) and two of the re-
searchers (FA and AT). The SVAI is based on the SWAP
trial from the UK [23], but delivered as a stratified inter-
vention (see below) and adapted to fit a Norwegian con-
text. The intervention emphasizes the assessment and
problem solving of modifiable health and work-related
obstacles to RTW, in collaboration with key stake-
holders. The physiotherapists follow a structured proto-
col during the intervention sessions, in which they also
document aspects of the intervention and obstacles to
RTW. The SVAI will be described in greater detail in a
separate process evaluation paper, but a brief description
is given here. In this arm of the trial participants will be
offered treatment that is matched to their risk subgroup
as follows:
 Participants at low/medium risk of long-term sick
leave (according to the screening) will be offered
one to two phone calls (lasting up to 1 h) containing
evidence-based advice on best current care for the
management of MSK pain and information and sup-
port to overcome obstacles associated with RTW. If
the participant requires further support to address
modifiable obstacles to RTW (e.g. if he/she is not
confident to RTW and/or can not specify when they
will return), a second phone consultation can be
conducted.
 Participants at high-risk of long-term sick leave will
be offered three to four sessions comprising
evidence-based advice on the management of MSK
pain and information and support to overcome ob-
stacles associated with RTW. The first session will
be conducted over the telephone, but the following
sessions can either be by phone or face-to-face, in-
cluding an optional worksite visit. If the participant
consents, written evidence-based information can be
sent to key stakeholders (the worker, employer, GP
and other healthcare professionals) in order to in-
form all involved about the intervention and encour-
age the coordination of their efforts to help the
participant overcome obstacles to RTW.
Outcomes
Baseline demographic data includes sociodemographic
and background information about sex, age, level of edu-
cation, marital status, first language, smoking, current
workability, use of painkillers and non-steroid anti-
inflammatory drugs (NSAIDs), sleeping medicine, and
physical activity level last week. Health literacy will be
assessed at baseline using the Health literacy Scale Nor-
wegian Questionnaire 12 (HLS-N-Q12) [24], a 12 item
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questionnaire covering: finding information about the
diagnosis, assessing pros and cons with different treat-
ments, following health instructions, assessing validity of
information, finding and understanding information,
and taking decisions for improved health. Sickness ab-
sence data will be delivered by NAV from registries. We
will apply for recorded data on the use of health care in
the National Patient Registry (NPR) and the national
registries for secondary and primary health care in
Norway.
Primary outcome
The primary outcome is the number of sickness absence
days from baseline assessment date until the 6-month
follow-up (main endpoint). We will convert time on sick
leave to days of sickness absence by combining informa-
tion from different national registries including informa-
tion on sick leave payments, sick leave certificates, work
assessment allowance (AAP), disability pensions and em-
ployment percentage. We will convert time on graded
sick leave to actual days away from work (according to a
five-day work week) adjusted for employment percent-
age. Any increase in disability pension during follow-up
will be counted as sick leave. AAP is paid every 14 days
and adjusted for how much a person has worked in this
period. To compute days of sickness absence for people
receiving AAP we will divide the actual payment by the
maximum possible payment, to estimate the proportion
of AAP that a given person has received. This will then
be transformed into days of sickness absence.
Secondary outcomes
1. The number of sickness absence days from baseline
until the 12-month follow-up (registry data).
2. Time until full sustained RTW (first 4-week period
of 50–100% return to original employment percent-
age without relapse) during 12 months of follow-up
(registry data).
3. The proportions of participants receiving sick leave
benefits during the 12 months of follow-up (registry
data).
4. Quality-adjusted life years (QALYs) measured by
the EuroQol-5 Dimentions-5 Levels (EQ-5D-5L).
5. MSK health at the 12-month follow-up will be
assessed by the MSK Health Questionnaire (MSK-
HQ). MSK-HQ has 15 items and is a recently devel-
oped questionnaire that captures key outcomes that
have shown to be highly relevant to patients across
a broad variety of MSK disorders presentations. It
has undergone initial psychometric testing in four
different MSK cohorts and demonstrated high com-
pletion rates, excellent test-retest reliability and
strong convergent validity with other disease-
specific outcomes [22].
Sample size
The sample size was calculated based on the estimates
from two previous trials, the first by Linton and col-
leagues [14] which was conducted in Sweden in a wel-
fare system similar to the Norwegian one, and the
second, the SWAP trial by Wynne-Jones and colleagues
[17] in the UK. Linton et al. found a difference of 11.3
sickness absence days in favor of the intervention group
(MI and problem-solving skills for the patient and their
work supervisor) compared to treatment as usual at 6
months, and the SWAP trial found a difference between
intervention and usual primary care of 5.1 days after 4
months. As there was no information about the standard
deviation (SD) in the study by Linton et al., we estimated
it using their results. Thus, we calculated a SD of 27.4 for
the difference of 11.3 days. The total number of sick days
was calculated from inclusion of the study until 6 months
later. Considering a difference of 10 days (SD 28) to be
clinically relevant between the usual care management
alone versus usual care management plus MI and between
usual case management alone versus usual case manage-
ment plus SVAI arm, and with statistical power of 80%
and significance level of 5%, we would need 125 individ-
uals per arm, in total 375 for this multi-arm RCT. Consid-
ering adjustment for expected skewed data for the
primary outcome (days of sick leave) with a factor of 1.1,
we estimated a sample size of 413 participants. Since the
primary work-related outcomes are based on registry data,
we anticipate there will be very little missing data, hence,
we adjusted for only 5% loss to follow-up, and so the esti-
mate is 434 participants, and we decided to include 450
participants in total (150 in each trial arm). To reduce loss
to follow-up for secondary outcomes, we will use several
initiatives such as brief questionnaires, sending reminders,
and provide English questionnaires for those who do not
speak/write Norwegian.
Identification, recruitment and randomization
Participants will be identified by the NAV Directorate by
weekly updated lists of people on sick leave due to MSK
disorders for > 7 weeks in the South-Eastern region of
Norway. Eligible participants will then be contacted by
telephone and asked if they would like to participate and
then screened for inclusion and exclusion criteria. If the
eligible individual confirms participation via telephone,
an electronic link with informed consent and question-
naires will be completed. We will administer the ques-
tionnaires to all participants electronically before
allocation to groups (baseline), and at 3-, 6-, 9-, and 12-
month thereafter. The timeline is illustrated in Table 1.
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Two computer-generated randomization lists will be
prepared by a blinded statistician, who will not be in-
volved in the allocation sequence: One list is prepared
for the high-risk subgroup and one list for the low/
medium risk subgroup. After stratification for high and
low/medium risk, a random number will be generated
from a range of 1 to 3 using random number generator
implemented in Matlab software (a 1:1:1 allocation
within each strata). The lists are unavailable for every-
one, except for the person who allocate the participants
(TR). The person who will allocate the participants will
contact the NAV case workers and the physiotherapists
offering the interventions by phone and will not be a
part of the recruitment ensuring concealed allocation. A
flow chart is depicted in Fig. 1.
Blinding
The researchers (assessors and statistician) will be
blinded to the allocation of participants, and the analyses
will be blinded. Participants, NAV caseworkers and
physiotherapists delivering the interventions will not be
blinded.
Statistical analyses
A statistical analysis plan (SAP) for the primary and sec-
ondary outcome analyses, and the economic evaluation,
is presented in Appendix I. A separate SAP for the me-
diation analyses and for the exploratory predictor ana-
lyses will be reported. The analysis will follow the
intention to treat principle and are described in detail in
the SAP. Cost-utility, cost-effectiveness and cost-benefit
analyses will be performed from a health and societal
perspective. The time horizon is 12 months. To measure
utilities the EQ-5D-5L utility index will be used [25].
The EQ-5D-5L is a generic and preference-weighted
measure of health-related quality-of-life based on five di-
mensions: mobility, self-care, activities of daily life, pain,
and anxiety and/or depression. For each dimension, the
patient assesses five possible levels of problems (from no
to severe) [25]. The participants complete the EQ-5D-5L
at baseline, and at the 3-, 6-, 9- and 12-months follow-
ups. Health gains will be expressed as QALYs. Health-
care utilization and work loss will be based upon public
registry data. In addition to public registry data on sick-
ness absence, production loss will also be measured by
the Institute for Medical Technology Assessment Prod-
uctivity Cost Questionnaire (iPCQ) [26], which assesses
absenteeism, presenteeism and unpaid work. The iPCQ
has been translated and culturally adapted to Norwegian
and found to have good measurement properties when
used among Norwegian patients with long-term MSK
disorders [27].
To compare participants with eligible people from the
general Norwegian population and thus to evaluate rep-
resentativeness of our sample, we will use anonymized
data from NAV on sociodemographic and work-related
variables (sex, age, diagnosis, graded disability pensions,
type of occupation and employment percentage. These
analyses will be conducted across different sub-
populations; 1) between trial participants and eligible
Table 1 The schedule of enrolment, interventions, and assessments
STUDY PERIOD
Enrolment Allocation Post-allocation (months) Long-term







Stratified vocational advice X (X)
Usual case management X (X) (X) (X) (X)
QUESTIONNAIRES
Education, marital status, smoking, work expectancy, HLS-N-Q12 X
Work ability, conflicts and well-being at work, medications, physical activity level,
STarT MSK, Örebro Musculoskeletal Pain Screening Questionnaire Short Form, Coping
from (ÖMPSQ full version), MSK-HQ, iPCQ, work situation, EQ-5D-5L
X X X X X
Global rating of change, medical/health treatment last 3 months X X X X
Return to work days X
HLS-N-Q12 Health Literacy Scale Questionnaire, STarT MSK Start Musculoskeletal tool, MSK-HQ Musculoskeletal Health Questionnaire, iPCQ the Institute for Medical
Technology Assessment Productivity Cost Questionnaire, EQ-5D-5L Euro Quality of Life 5 Dimensions 5 Levels
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people from the same geographic area in Norway; 2) be-
tween trial participants and eligible people from the
whole of Norway; 3) between trial participants from the
present MI-NAV project and trial participants in a simi-
lar ongoing trial in Trondheim [28].
Process evaluations of MI and SVAI
We will conduct process evaluations of both the MI and
SVAI interventions using a mixed-methods design. The
usual case management will be described in WP1 of the
MI-NAV Study. The process evaluation involves investi-
gating which factors promote and restrain the imple-
mentation, and acceptability and maintenance of the two
interventions. In addition to the fidelity and adherence
scorings described below, the content of audio-
recordings and recorded data from the MI- and SVAI-
conversations will be explored by qualitative methods.
Whether the interventions are delivered as intended will
be assessed through audio-recordings of approximately
10% of the intervention sessions (in the two intervention
arms). Recordings of the conversations between the par-
ticipants and either the NAV caseworkers or physiother-
apists will be done throughout the intervention period.
In addition, we will log the number of participants per
NAV caseworker and SVAI physiotherapist so that those
who have the most participants will perform the most
recordings. The fidelity of the MI conversations will be
scored and coded using the Motivational Interviewing
Treatment Integrity Code version 4 (MITI 4) [29]. This
scoring will be done by trained people at the KoRus MI-
analysis Center in Bergen (https://www.korusbergen.no/
motiverende-samtale/mi-analyse/), who are not part of
the research group. We will document and report mean
and percentages of MITI scores, representing degree of
MI competence, as well as more detailed analyses of the
change in MITI scores over time.
Fig. 1 Flow chart of study participants in the randomized controlled trial
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We will record adherence in the two intervention arms
as numbers and percentages of participants who have re-
ceived the intervention according to the protocols. For
the MI arm, adherence will be defined as receiving two
sessions in which at least one of them should be face-to-
face meeting. For the SVAI intervention adherence will
be defined as receiving one or two sessions (phone calls
only) in the low/medium-risk group and three or four
sessions either by phone or face-to-face in the high-risk
group. In addition, a SVAI log should be completed, in-
dicating that the structured intervention protocol has
been followed. The SVAI log is a document kept by the
SVAI physiotherapists for each participant in that arm
containing themes that the physiotherapist should ask
about during the conversation (i.e. obstacles for RTW,
RTW plan, contact with employer, health situation, work
situation). We will also report the number of face-to-
face sessions and the number of workplace meetings in
the high-risk subgroup.
Mediators
The two possible mediators of the association between the
interventions and number of sickness absence days at 6
months, workability and RTW expectancy, will be assessed
as follows: Workability will be assessed by one single item
from the Finnish Work Ability Index (WAI) [30] recording
“current workability compared with the lifetime best” on a
0–10 numerical rating scale. Work expectancy assessed by
one question from the ÖMPSQ-SF (“In your estimation,
what are the chances you will be working your normal du-
ties in 3 months”) and a question on how long they think
they will be on sick leave (< 2months; 2–4months; 4–10
months, or > 10months).
Predictors
To evaluate whether any subgroup of participants have a
different treatment effect on the primary outcome at 12
months follow-up we will conduct exploratory analyses
on predefined predictors (e.g. the risk groups). A separ-
ate SAP will be worked out for these analyses and pub-
lished at clinicaltrials.gov.
User involvement
In the planning of the RCT, we consulted an established
user panel1 with representatives from different patient
organizations for people with MSK disorders. They gave
feedback related to the relevance, aim and conduction of
the study. The user representatives considered the study
to be important and of high relevance to people with
MSK disorders. Members from the user panel helped
with the wording of the information letter and the devel-
opment of the recruitment telephone script. We plan to
involve users in interpreting the data, drafting the manu-
scripts and disseminating the results.
Ethical considerations
The study protocol was submitted to the Regional Com-
mittees for Medical and Health Research Ethics for health
research. They concluded that the study did not need ap-
proval by the Committee since the study does not gener-
ate new health research (2018/1326/REK sør-øst A). The
Norwegian Center for Research Data has assessed and ap-
proved the project. The study will be conducted according
to the Helsinki declaration. Data will be stored on Services
for Sensitive Data (TSD) at the University of Oslo on se-
cured research servers with access only for researchers
directly involved in the project.
Discussion
The Norwegian Directorate of Health encourages health
care providers to use MI to support health behavior
change, and MI is used in NAV to facilitate RTW des-
pite little research supporting the use of MI in people
with MSK disorders [8]. To be able to give evidence-
based recommendations on the effectiveness and cost-
effectiveness of MI on RTW, there is a need for large
RCTs. Whilst other vocational advice interventions have
shown promising results in improving RTW outcomes
in individuals with MSK disorders [17, 31], a stratified
vocational advice intervention provided by physiothera-
pists, as included in this RCT, has not been studied pre-
viously. In this multi-arm RCT all participants receive
usual case management by NAV and the two interven-
tion groups receive additionally either MI or SVAI. This
design enables us to examine the additional effect of the
vocational interventions to the usual case management,
however, we have not designed the study to compare the
two interventions head-to-head, as this would have re-
quired an unrealistically large sample size. The primary
outcome is the number of sick leave days from inclusion
to the 6-month follow-up, and the sample size calcula-
tion is based on this follow-up time-point with an ex-
pected difference between the intervention groups and
the usual case management group of 10 days.
Experienced professionals will educate both the NAV
caseworkers and the SVAI physiotherapists to provide
the interventions. However, it is difficult to conduct MI
correctly with little experience [6]. Therefore, we will
pay close attention to how the NAV caseworkers and
the SVAI physiotherapists will use and develop their
skills in the interventions through audiotaping the ses-
sions, score the MI interventions, and conduct monthly
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Conducting RCTs with people on sick leave is
dependent upon the willingness of these people to partici-
pate in research. A previous RCT on the effectiveness of
inpatient multicomponent occupational rehabilitation
found that less than 10% of eligible participants accepted
the trial invitation [32]. Thus, we have tried to keep the
questionnaires as short as possible to prevent missing
data. We will have data from all the participants on the
main outcome from NAV registries and we will perform
the analyses according to the intention-to-treat principle
to reduce the impact of attrition bias. Nevertheless, we
need more knowledge of the group that is willing to par-
ticipate in research as compared to those who do not par-
ticipate. This will be addressed by comparing registry data
of those who are willing and those who do not participate
in this RCT and the other similar ongoing RCT in Norway
[28]. The results of the RCT will provide evidence of the
clinical and cost-effectiveness of MI and SVAI in addition
to usual NAV case management in Norway.
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